These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11739448)

  • 1. Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and IGF-I.
    Ciaraldi TP; Carter L; Seipke G; Mudaliar S; Henry RR
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5838-47. PubMed ID: 11739448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I.
    Ciaraldi TP; Phillips SA; Carter L; Aroda V; Mudaliar S; Henry RR
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5551-8. PubMed ID: 16030168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and insulin-like growth factor-1 action on human skeletal muscle: preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects.
    Ciaraldi TP; Carter L; Rehman N; Mohideen P; Mudaliar S; Henry RR
    Metabolism; 2002 Sep; 51(9):1171-9. PubMed ID: 12200763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
    Chisalita SI; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites.
    Sommerfeld MR; Müller G; Tschank G; Seipke G; Habermann P; Kurrle R; Tennagels N
    PLoS One; 2010 Mar; 5(3):e9540. PubMed ID: 20209060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.
    Eckardt K; May C; Koenen M; Eckel J
    Diabetologia; 2007 Dec; 50(12):2534-43. PubMed ID: 17898992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and mitogenic effects of IGF-II in rainbow trout (Oncorhynchus mykiss) myocytes in culture and the role of IGF-II in the PI3K/Akt and MAPK signalling pathways.
    Codina M; García de la serrana D; Sánchez-Gurmaches J; Montserrat N; Chistyakova O; Navarro I; Gutiérrez J
    Gen Comp Endocrinol; 2008 Jun; 157(2):116-24. PubMed ID: 18504044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells.
    Furling D; Marette A; Puymirat J
    Endocrinology; 1999 Sep; 140(9):4244-50. PubMed ID: 10465298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
    Johansson GS; Arnqvist HJ
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
    Chisalita SI; Nitert MD; Arnqvist HJ
    Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor-alpha on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects.
    Ciaraldi TP; Carter L; Mudaliar S; Kern PA; Henry RR
    Endocrinology; 1998 Dec; 139(12):4793-800. PubMed ID: 9832415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor.
    Yehezkel E; Weinstein D; Simon M; Sarfstein R; Laron Z; Werner H
    Diabetologia; 2010 Dec; 53(12):2667-75. PubMed ID: 20835859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review on the in vitro interaction of insulin glargine with the insulin/insulin-like growth factor system: potential implications for metabolic and mitogenic activities.
    Ciaraldi TP; Sasaoka T
    Horm Metab Res; 2011 Jan; 43(1):1-10. PubMed ID: 20938889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.
    Kurtzhals P; Schäffer L; Sørensen A; Kristensen C; Jonassen I; Schmid C; Trüb T
    Diabetes; 2000 Jun; 49(6):999-1005. PubMed ID: 10866053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin.
    Wada T; Azegami M; Sugiyama M; Tsuneki H; Sasaoka T
    Diabetes Res Clin Pract; 2008 Sep; 81(3):269-77. PubMed ID: 18585815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
    Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
    Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of noninsulin-dependent diabetes mellitus subjects.
    Federici M; Zucaro L; Porzio O; Massoud R; Borboni P; Lauro D; Sesti G
    J Clin Invest; 1996 Dec; 98(12):2887-93. PubMed ID: 8981937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic effect of the insulin analogue glargine in malignant cells in comparison with insulin and IGF-I.
    Liefvendahl E; Arnqvist HJ
    Horm Metab Res; 2008 Jun; 40(6):369-74. PubMed ID: 18393172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells.
    Baudry A; Lamothe B; Bucchini D; Jami J; Montarras D; Pinset C; Joshi RL
    FEBS Lett; 2001 Jan; 488(3):174-8. PubMed ID: 11163767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.